Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inspiratory muscle fatigue and pulmonary deposition/perfusion imaging predict sleep dysfunction in long COVID: Evidence from MTC scintigraphy and FIT performance metrics.

Respiratory medicine·2026
Same author

Effect of Inspiratory Muscle Training on Aerosol Deposition and Pulmonary Perfusion in Post-COVID-19 Syndrome: A Gamma Scintigraphy Study.

Journal of aerosol medicine and pulmonary drug delivery·2026
Same author

Aerosol Delivery to an Adult Model via High-Flow Nasal Cannula with Inspiration-Synchronized Small-Particle Vibrating Mesh Nebulizer.

Journal of aerosol medicine and pulmonary drug delivery·2025
Same author

Impact of normal, obstructive, and restrictive breathing patterns on aerosol drug delivery with jet and mesh nebulizers in simulated spontaneously breathing adults.

Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR·2025
Same author

<i>In Vitro</i> Comparison of Inspiration-Synchronized and Continuous Vibrating Mesh Nebulizer During Adult Invasive Mechanical Ventilation.

Journal of aerosol medicine and pulmonary drug delivery·2024
Same author

Efficacy of a prototype inspiratory-synchronized small particle versus conventional vibrating mesh nebulizer during pediatric and neonatal mechanical ventilation.

Pediatric pulmonology·2024

Related Experiment Video

Updated: May 12, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Inhaler devices for patients with COPD.

James B Fink1, Gene L Colice, Rick Hodder

  • 1Respiratory Therapy Program at Georgia State University, Atlanta, GA, USA. Fink.jim@gmail.com

COPD
|March 30, 2013
PubMed
Summary
This summary is machine-generated.

Managing chronic obstructive pulmonary disease (COPD) requires proper inhaler technique. Understanding device-specific and patient-specific factors is key for optimal medication delivery and improved COPD treatment outcomes.

More Related Videos

Disposable Dosators Intended for Dry Powder Delivery to Mice
04:59

Disposable Dosators Intended for Dry Powder Delivery to Mice

Published on: August 18, 2023

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

Related Experiment Videos

Last Updated: May 12, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Disposable Dosators Intended for Dry Powder Delivery to Mice
04:59

Disposable Dosators Intended for Dry Powder Delivery to Mice

Published on: August 18, 2023

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

Area of Science:

  • Pulmonary Medicine
  • Respiratory Care
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) remains a significant cause of morbidity and mortality despite advances in understanding and treatment guidelines.
  • Key features of COPD include progressive airflow limitation and hyperinflation, necessitating effective pharmacotherapy delivery.
  • A wide array of inhaler devices are available, each with unique operational and maintenance requirements.

Purpose of the Study:

  • To highlight the challenges in optimizing pulmonary drug delivery for COPD patients.
  • To emphasize the importance of patient-device interaction in achieving therapeutic goals.
  • To discuss how next-generation inhalers and tailored approaches can improve COPD management.

Main Methods:

  • Review of current literature on COPD pharmacotherapy and inhaler technologies.
  • Analysis of factors influencing inhaler efficacy, including device design and patient adherence.
  • Discussion of clinical considerations for matching inhaler devices to individual patient needs.

Main Results:

  • The selection and proper use of inhaler devices are critical for effective COPD treatment.
  • Patient understanding, maintenance, and correct usage of inhaler devices are essential for consistent drug delivery.
  • Successful management necessitates addressing patient-specific physical and psychosocial factors influencing inhaler use.

Conclusions:

  • Next-generation inhalers offer potential for improved drug delivery in COPD.
  • Awareness of device-specific and patient-specific variables is crucial for optimizing inhaler use.
  • Personalized approaches to inhaler selection and education may enhance clinical outcomes in COPD management.